Abstract
Lower respiratory tract infections (LRTIs) and tuberculosis represent some of top health priorities in Europe. In this report the most recent advances in the field of disease control, clinical research and basic science of LRTIs and tuberculosis are presented through the analysis of some of the best abstracts presented at the 19th ERS Congress in Vienna.
Pathogenesis, diagnosis, treatment, prognostic factors, and novel diagnostic techniques relevant for bacterial and viral infections as well as new tools for the diagnosis of latent and active tuberculosis in different sub-groups of patients are discussed. The growing epidemiological threat represented by multidrug-resistant (MDR-) and extensively drug-resistant (XDR-) tuberculosis cases is presented and its impact analysed.
Footnotes
- ERS